CSIMarket
 


Vir Biotechnology Inc   (VIR)
Other Ticker:  
 

Vir Biotechnology Inc Profitability Comparisons

Select each Category to receive further Information


VIR Profitability Ratio

Company Industry Sector S&P 500
Gross Margin (Q3 MRQ) 94.06 % 60.33 % 48.18 % 46.64 %
Gross Margin (Q3 TTM) 91.71 % 62.4 % 49.29 % 46.18 %
Gross Margin 5 Yr. Avg. - 68.04 % 50.35 % 47.7 %
EBITDA Margin (Q3 MRQ) 58.58 % 16.74 % 11.81 % 18.46 %
EBITDA Margin (Q3 TTM) 61.29 % 10.02 % 12.29 % 19.27 %
EBITDA Margin 5 Yr. Avg. - 26.03 % 15.18 % 37.84 %
Operating Margin (Q3 MRQ) 52.05 % 12.24 % 8.3 % 15.55 %
Operating Margin (Q3 TTM) 65.37 % 11.78 % 9.9 % 16.28 %
Operating Margin 5 Yr. Avg. - 18.96 % 10.68 % 14.62 %
Pre-Tax Margin (Q3 MRQ) 58.13 % 9.28 % 5.16 % 11.11 %
Pre-Tax Margin (Q3 TTM) 61.02 % 3.33 % 5.65 % 11.99 %
Pre-Tax Margin 5 Yr. Avg. - 20.06 % 8.83 % 19.12 %
Net Margin (Q3 MRQ) 46.81 % 4.61 % 4.32 % 8.81 %
Net Margin (Q3 TTM) 48.03 % 1.14 % 4.33 % 9.66 %
Net Margin 5 Yr. Avg. - 13.71 % 7.02 % 15.07 %



Company's Cashflow Profitability & Other



Profitability Ratios Company Industry Sector S&P 500
Free Cash Flow Margin (Q3 MRQ) 31.48 % 6.47 % 7.34 % 8.43 %
Free Cash Flow Margin (Q3 TTM) 68.76 % - - -
Free Cash Flow Margin 5 Yr. Avg.